Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.529 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.41.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.14.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
LQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used